CDKN2A and familial pancreatic carcinoma: It should be mentioned that among the major categories of human tumors, the highest rate of CDKN2A mutations has been found in pancreatic cancer [17, 30], and that the mutational spectrum of pancreatic cancer is comparable to the overall spectrum of mutations in CUP detected by us and others [14, 17, 30].